EPS (Diluted) for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's current diluted EPS (TTM) is $23.03. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$23.03
YoY change
+1.8%
5Y CAGR
+20.6%
Peak year (2025)
$23.03
Latest annual
$23.03
EPS (Diluted) history chart for Novo Nordisk (NVO) from 1985 to 2025
EPS (Diluted) history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $23.03 | +1.8% | ||
| 2024 | $22.63 | +21.5% | ||
| 2023 | $18.62 | +52.4% | ||
| 2022 | $12.22 | +17.8% | ||
| 2021 | $10.37 | +15.1% | ||
| 2020 | $9.01 | +10.0% | ||
| 2019 | $8.19 | +2.8% | ||
| 2018 | $7.97 | +3.5% | ||
| 2017 | $7.70 | +2.9% | ||
| 2016 | $7.48 | +10.7% | ||
| 2015 | $6.76 | +34.1% | ||
| 2014 | $5.04 | +7.7% | ||
| 2013 | $4.68 | +20.3% | ||
| 2012 | $3.89 | +29.7% | ||
| 2011 | $3.00 | +22.0% | ||
| 2010 | $2.46 | +38.2% | ||
| 2009 | $1.78 | +14.8% | ||
| 2008 | $1.55 | +15.7% | ||
| 2007 | $1.34 | +34.0% | ||
| 2006 | $1.00 | +12.4% | ||
| 2005 | $0.89 | +20.3% | ||
| 2004 | $0.74 | +4.2% | ||
| 2003 | $0.71 | +20.3% | ||
| 2002 | $0.59 | +5.4% | ||
| 2001 | $0.56 | +27.3% | ||
| 2000 | $0.44 | +29.4% | ||
| 1999 | $0.34 | +3.0% | ||
| 1998 | $0.33 | +13.8% | ||
| 1997 | $0.29 | +20.8% | ||
| 1996 | $0.24 | +14.3% | ||
| 1995 | $0.21 | +10.5% | ||
| 1994 | $0.19 | 0.0% | ||
| 1993 | $0.19 | +11.8% | ||
| 1992 | $0.17 | +6.3% | ||
| 1991 | $0.16 | +33.3% | ||
| 1990 | $0.12 | +29.7% | ||
| 1989 | $0.09 | -28.8% | ||
| 1988 | $0.13 | +36.8% | ||
| 1987 | $0.10 | -13.6% | ||
| 1986 | $0.11 | -8.3% | ||
| 1985 | $0.12 | — |
EPS (Diluted) values are taken from Novo Nordisk's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
The 2025 reading of Novo Nordisk (NVO) diluted EPS is $23.03 – edged up 1.8% year-over-year.
Novo Nordisk diluted EPS has grown for 31 consecutive years, with a +20.6% compound annual growth rate over 2020–2025 (5 years).
$23.03 stands as the all-time-high annual diluted EPS, posted in 2025, against a low of $0.09 during 1989.
Novo Nordisk (NVO) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Novo Nordisk EPS (Diluted) by Year
Novo Nordisk EPS (Diluted) 2025: $23.03
Novo Nordisk diluted EPS in 2025 was $23.03, edged up 1.8% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk EPS (Diluted) 2024: $22.63
Novo Nordisk diluted EPS in 2024 was $22.63, grew 21.5% from 2023.
Novo Nordisk EPS (Diluted) 2023: $18.62
Novo Nordisk diluted EPS in 2023 was $18.62, surged 52.4% from 2022.
Novo Nordisk EPS (Diluted) 2022: $12.22
Novo Nordisk diluted EPS in 2022 was $12.22, grew 17.8% from 2021.
Novo Nordisk EPS (Diluted) 2021: $10.37
Novo Nordisk diluted EPS in 2021 was $10.37.
See more financial history for Novo Nordisk (NVO).
Sector peers — EPS (Diluted)
Companies in the same sector as Novo Nordisk, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $17.74 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Novo Nordisk's diluted EPS?
- Latest reported diluted EPS for Novo Nordisk (NVO) is $23.03 (period ending December 31, 2025).
How has Novo Nordisk diluted EPS changed year-over-year?
- Novo Nordisk (NVO) diluted EPS changed +1.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk diluted EPS?
- Novo Nordisk (NVO) diluted EPS compound annual growth rate is +20.6% over the most recent 5 years available.
When did Novo Nordisk diluted EPS hit its highest annual value?
- Novo Nordisk diluted EPS reached its highest annual value of $23.03 in 2025.
What was Novo Nordisk diluted EPS in 2024?
- Novo Nordisk (NVO) diluted EPS in 2024 was $22.63.
What was Novo Nordisk diluted EPS in 2025?
- Novo Nordisk (NVO) diluted EPS in 2025 was $23.03.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.